Skip to main content
. 2007 Feb 19;93(10):1256–1262. doi: 10.1136/hrt.2006.110171

Table 4 RRs for use of statins and achievement of indicators in eligible patients with and without serious mental health problems.

Outcome Schizophrenia* Bipolar disorder*
Unadjusted RR(95% CI) Adjusted RR† (95% CI) Unadjusted RR (95% CI) Adjusted RR† (95% CI)
Prescribed statins ever 0.87 (0.81 to 0.94) 0.85 (0.80 to 0.91) 0.98 (0.93 to 1.04) 0.99 (0.94 to 1.04)
Prescribed statin in previous 12 months 0.88 (0.81 to 0.95) 0.85 (0.80 to 0.92) 0.96 (0.90 to 1.03) 0.97 (0.90 to 1.05)
CHD2: exercise testing or referral for newly diagnosed angina 0.68 (0.47 to 0.99) 0.69 (0.48 to 0.98) 1.08 (0.91 to 1.28) 1.10 (0.94 to 1.29)
CHD3: smoking status recorded in previous 15 months 1.00 (0.98 to 1.02) 1.00 (0.98 to 1.02) 1.02 (1.00 to 1.03) 1.02 (1.00 to 1.03)
CHD4: smoking cessation advice in previous 15 months 1.00 (0.96 to 1.04) 1.00 (0.96 to 1.04) 1.04 (1.02 to 1.07) 1.04 (1.01 to 1.07)
CHD5: blood pressure recorded in previous 15 months 1.00 (0.99 to 1.02) 1.00 (0.99 to 1.02) 1.01 (1.00 to 1.02) 1.01 (1.00 to 1.02)
CHD6: latest blood pressure value ⩽150/90 mm Hg in previous 15 months 1.00 (0.96 to 1.04) 1.01 (0.96 to 1.05) 1.00 (0.96 to 1.04) 1.01 (0.96 to 1.06)
CHD7: cholesterol recorded in previous 15 months 0.93 (0.89 to 0.97) 0.94 (0.90 to 0.98) 1.02 (1.00 to 1.04) 1.03 (1.01 to 1.05)
CHD8: latest cholesterol value ⩽5 mmol/l in previous 15 months 0.96 (0.89 to 1.03) 0.99 (0.92 to 1.06) 0.96 (0.90 to 1.03) 1.00 (0.92 to 1.08)
CHD9: aspirin, antiplatelet or anticoagulant in previous 15 months 0.99 (0.95 to 1.02) 1.00 (0.97 to 1.04) 1.00 (0.97 to 1.03) 1.01 (0.98 to 1.04)
CHD9: current treatment with β blocker 0.96 (0.88 to 1.05) 0.97 (0.88 to 1.06) 1.04 (0.96 to 1.12) 1.05 (0.98 to 1.13)

CHD, coronary heart disease.

*Schizophrenia group includes 39 patients with both schizophrenia and bipolar disorder; bipolar group includes patients with bipolar disorder only.

†Adjusted for age, sex, deprivation, diabetes and stroke, and allowing for clustering within practice; also adjusted for smoking except for indicators CHD3 and CHD4.